Close Menu

NEW YORK (GenomeWeb) – Opko Health reported after the close of the markets Monday that its first quarter revenues jumped ninefold compared to Q1 2015. The company said the surge was due in large part to revenues from clinical lab Bio-Reference Laboratories, which Opko acquired in August 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.